Vaccine Antigen Substance Validation Procedure

$79 / year

This dataset is a Structured Product Labeling (SPL) Terminology File for SPL validation procedures and contains information on performing SPL validation regarding Vaccine Antigen Substances.

Complexity

Validation procedures can be used by humans as check-lists to verify if their submission is correct. These are written specific and operational so that they may be checked by systems processing SPL documents.

Date Created

2014-08-29

Last Modified

2017-10-13

Version

2017-10-13

Update Frequency

Irregular

Temporal Coverage

N/A

Spatial Coverage

N/A

Source

John Snow Labs => US Food & Drug Administration (FDA)

Source License URL

John Snow Labs Standard License

Source License Requirements

N/A

Source Citation

N/A

Keywords

Product Labels, Structured Product Labels, SPL, Live Vaccines List, Live Attenuated Vaccine, Vaccines Antigen Validation

Other Titles

Vaccine Antigens Validation Procedure, Vaccine Substances Validation File

Name Description Type Constraints
Vaccine_UNIIUnique Ingredient Identifier for the vaccinestringrequired : 1
Preferred_TermUNII Preferred Term - Preferred Substance Name - display namestringrequired : 1
Vaccine_UNIIPreferred_Term
K11WX7434XPOLIOVIRUS TYPE 1 LIVE ANTIGEN
FX373BC7I1POLIOVIRUS TYPE 2 LIVE ANTIGEN
X3QRF7812EPOLIOVIRUS TYPE 3 LIVE ANTIGEN
0MZI008M96SALMONELLA TYPHI TY21A LIVE ANTIGEN
63GD90PP8XBORDETELLA PERTUSSIS PERTACTIN ANTIGEN
1O0600285ABORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN
760T5R8B3OSALMONELLA ENTERICA SEROVAR TYPHI ANTIGEN
873OI62848BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS
7194H8W3KTSALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN
PY4EET359TYELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN